A multicenter clinical trial of Gadolite Oral Suspension as a contrast agent for MRI.
Rubin DL, Falk KL, Sperling MJ, Ross M, Saini S, Rothman B, Shellock F, Zerhouni E, Stark D, Outwater EK, Schmiedl U, Kirby LC, Chezmar J, Coates T, Chang M, Silverman JM, Rofsky N, Burnett K, Engel J, Young SW.
Rubin DL, et al.
J Magn Reson Imaging. 1997 Sep-Oct;7(5):865-72. doi: 10.1002/jmri.1880070515.
J Magn Reson Imaging. 1997.
PMID: 9307913
Clinical Trial.